158 related articles for article (PubMed ID: 32641652)
1. Acquired Gray Platelet Syndrome Associated with Primary Myelofibrosis.
Ido K; Nakane T; Tanizawa N; Makuuchi Y; Okamura H; Koh S; Nanno S; Nishimoto M; Hirose A; Nakamae M; Nakashima Y; Koh H; Hino M; Nakamae H
Intern Med; 2020 Nov; 59(21):2751-2756. PubMed ID: 32641652
[TBL] [Abstract][Full Text] [Related]
2. Correction of Severe Myelofibrosis, Impaired Platelet Functions and Abnormalities in a Patient with Gray Platelet Syndrome Successfully Treated by Stem Cell Transplantation.
Favier R; Roussel X; Audia S; Bordet JC; De Maistre E; Hirsch P; Neuhart A; Bedgedjian I; Gkalea V; Favier M; Daguindau E; Nurden P; Deconinck E
Platelets; 2020 May; 31(4):536-540. PubMed ID: 31502501
[TBL] [Abstract][Full Text] [Related]
3. Severe acquired platelet dysfunction because of primary myelofibrosis with full functional and morphological recovery after allogeneic hematopoietic cell transplantation.
Linnik YA; Salvatore LT; Lowrey CH; Ornstein DL
Blood Coagul Fibrinolysis; 2019 Dec; 30(8):419-422. PubMed ID: 31483321
[TBL] [Abstract][Full Text] [Related]
4. Practical management of the haemorrhagic complications of myeloproliferative neoplasms.
Jones E; Dillon B; Swan D; Thachil J
Br J Haematol; 2022 Nov; 199(3):313-321. PubMed ID: 35724983
[TBL] [Abstract][Full Text] [Related]
5. Gray Platelet Syndrome-Unusual Presentation with Spontaneous Splenic Rupture: A Case Report and Literature Review.
Barghouthi DI; Abu-Hilal LH; Njoum Y; Hasan AD; Alshawwa K; Hourani F
J Investig Med High Impact Case Rep; 2023; 11():23247096231196697. PubMed ID: 37649376
[TBL] [Abstract][Full Text] [Related]
6. Gray Platelet Syndrome Presenting With Pancytopenia, Splenomegaly, and Bone Marrow Fibrosis.
Tariq H; Perez Botero J; Higgins RA; Medina EA
Am J Clin Pathol; 2021 Jul; 156(2):253-258. PubMed ID: 33586768
[TBL] [Abstract][Full Text] [Related]
7. A novel nonsense NBEAL2 gene mutation causing severe bleeding in a patient with gray platelet syndrome.
Cao L; Su J; Li J; Yu Z; Bai X; Wang Z; Xia L; Ruan C
Platelets; 2018 May; 29(3):288-291. PubMed ID: 28504079
[TBL] [Abstract][Full Text] [Related]
8. A Case of Chronic Thrombocytopenia in a 17-Year-Old Female.
Riley R; Khan A; Pai S; Warmke L; Winkler M; Gunning W
Lab Med; 2019 Oct; 50(4):406-420. PubMed ID: 31228350
[TBL] [Abstract][Full Text] [Related]
9. Gray platelet syndrome with splenomegaly and signs of extramedullary hematopoiesis: a case report with review of the literature.
Jantunen E; Hänninen A; Naukkarinen A; Vornanen M; Lahtinen R
Am J Hematol; 1994 Jul; 46(3):218-24. PubMed ID: 8192152
[TBL] [Abstract][Full Text] [Related]
10. The platelet-cancer loop in myeloproliferative cancer. Is thrombocythemia an enhancer of cancer invasiveness and metastasis in essential thrombocythemia, polycythemia vera and myelofibrosis?
Hasselbalch HC
Leuk Res; 2014 Oct; 38(10):1230-6. PubMed ID: 25149709
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic Purpura With Gray Platelets: an Acquired Form of Gray Platelet Syndrome.
Lee AC
J Pediatr Hematol Oncol; 2019 Jan; 41(1):47-50. PubMed ID: 30334901
[TBL] [Abstract][Full Text] [Related]
12. [Acquired platelet dysfunction with severe bleeding tendency in triple-negative myelofibrosis].
Momose H; Nishikii H; Kozuma Y; Ota-Tsutsumi I; Nannya Y; Yoshida C; Komeno T; Kusakabe M; Yokoyama Y; Kato T; Kurita N; Sootome A; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Ogawa S; Chiba S
Rinsho Ketsueki; 2021; 62(9):1406-1411. PubMed ID: 34615801
[TBL] [Abstract][Full Text] [Related]
13. A case of gray platelet syndrome masked by immune thrombocytopenia at presentation.
Mizuno N; Kanamori E; Saito H; Murakami N; Tojo N; Tohda S
Acta Haematol; 2014; 132(2):163-5. PubMed ID: 24577417
[TBL] [Abstract][Full Text] [Related]
14. Gray platelet syndrome: Management of perioperative bleeding in redo cardiac surgery.
Carrascal Y; Laguna G; Blanco M; Segura B; Martínez-Almeida I
J Card Surg; 2020 Feb; 35(2):457-459. PubMed ID: 31710726
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria.
Finazzi G; Carobbio A; Thiele J; Passamonti F; Rumi E; Ruggeri M; Rodeghiero F; Randi ML; Bertozzi I; Vannucchi AM; Antonioli E; Gisslinger H; Buxhofer-Ausch V; Gangat N; Rambaldi A; Tefferi A; Barbui T
Leukemia; 2012 Apr; 26(4):716-9. PubMed ID: 21926959
[TBL] [Abstract][Full Text] [Related]
16. Massive platelet transfusion after splenectomy in a case of myelofibrosis.
Toolis F; Paton L
Scand J Haematol; 1979 Oct; 23(4):317-22. PubMed ID: 538414
[TBL] [Abstract][Full Text] [Related]
17. [Investigation and treatment of prefibrotic/early primary myelofibrosis. A case study].
Magyari F; Bedekovics J; Décsy J; Ilonczai P; Illés Á; Simon Z
Orv Hetil; 2018 Apr; 159(15):603-609. PubMed ID: 29631428
[TBL] [Abstract][Full Text] [Related]
18. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
Barbui T; Cortelazzo S; Viero P; Bassan R; Dini E; Semeraro N
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171
[TBL] [Abstract][Full Text] [Related]
19. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p.
Gunay-Aygun M; Zivony-Elboum Y; Gumruk F; Geiger D; Cetin M; Khayat M; Kleta R; Kfir N; Anikster Y; Chezar J; Arcos-Burgos M; Shalata A; Stanescu H; Manaster J; Arat M; Edwards H; Freiberg AS; Hart PS; Riney LC; Patzel K; Tanpaiboon P; Markello T; Huizing M; Maric I; Horne M; Kehrel BE; Jurk K; Hansen NF; Cherukuri PF; Jones M; Cruz P; Mullikin JC; Nurden A; White JG; Gahl WA; Falik-Zaccai T
Blood; 2010 Dec; 116(23):4990-5001. PubMed ID: 20709904
[TBL] [Abstract][Full Text] [Related]
20. Abnormal platelet function in myelofibrosis.
Didisheim P; Bunting D
Am J Clin Pathol; 1966 May; 45(5):566-73. PubMed ID: 5939950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
